Market Insight Blog

Social Security Double Taxation Does Exist in These 13 States
There's no question that this has been a challenging year for all Americans. The coronavirus disease 2019 (COVID-19) pandemic has completely upended societal norms, driven more than 20 million people out of work, and caused a level of panic and uncertainty that hasn't been seen in a really long time. But amid the chaos, the nation's most storied social program, Social Security, continues to be a rock for nearly 65 million Americans, many of whom are senior citizens. The Social Security program […]

read more
Luckin Coffee Board Fails in an Attempt to Remove Chairman
Charles Zhengyao Lu is keeping his job at Luckin Coffee (OTC: LKNC.Y), the company announced in a regulatory document filed after market hours on Thursday. Its board of directors held a meeting to remove him as board member and chairman, but the board did not gain the two-thirds majority needed to eject Lu. The move will be seen as the latest setback for the troubled Chinese coffee maker and retailer. This cascade of problems began early this year with the revelation that it inflated the […]

read more
Why Carvana Stock Rose 29% Last Month
What happened Shares of Carvana (NYSE: CVNA) were climbing last month as a series of bullish analyst reports, positive third-party data, and momentum from the recovery pushed the online used car dealer higher. According to data from S&P Global Market Intelligence, the stock finished June up 29%. As you can see from the chart below, the stock's gains were uneven, but it still finished sharply higher. CVNA data by YCharts. So what Carvana stock jumped 19% on June 2, though there wasn't a clear […]

read more
Why Planet Fitness Stock Was Down 19% in the First Half of 2020
What happened Shares of gym chain Planet Fitness (NYSE: PLNT) fell 18.9% in the first half of 2020, according to data provided by S&P Global Market Intelligence. To say it's been a bumpy ride is an understatement. From February to March, the stock was down around 70%, but then it climbed right back to where it started the year. Planet Fitness stock is actually down 19% in just the last month. And a June 29 press release from the Monongalia County Health Department in West Virginia […]

read more
Hamilton Special: 3 Hot Stocks Under $10
We're all streaming Hamilton on Friday with the Disney+ debut of the Broadway smash musical. Alexander Hamilton happens to grace the face of our $10 bill, so let's explore some compelling stocks that you can buy for a Hamilton or less per share. CenturyLink (NYSE: CTL), Sirius XM Holdings (NASDAQ: SIRI), and Zynga (NASDAQ: ZNGA) are some of the stocks with single shares trading for less than that $10 bill in your pocket. Let's see why -- as Lin-Manuel Miranda would sing -- you shouldn't be […]

read more
Why Moderna Shares Climbed 228.3% in the First Half
What happened Moderna (NASDAQ: MRNA) shares soared 228.3% in the first half, according to data provided by S&P Global Market Intelligence, as the company advanced its COVID-19 vaccine through clinical studies and announced promising early data. Image source: Getty Images. Moderna became the first company to begin clinical trials on a vaccine as the coronavirus spread throughout the world. The company's vaccine candidate entered a phase 1 study in March, then began phase 2 in May. Interim […]

read more
Is Grubhub Stock a Buy?
Grubhub (NYSE: GRUB) took investors on a roller-coaster ride after its IPO in April 2014. The food delivery company went public at $26 per share, and its stock had surged to nearly $150 by late 2018. However, intense competition, surging expenses, and the COVID-19 crisis caused Grubhub to drop back to the low $30s earlier this year. But Grubhub's stock rebounded to the high $60s last month after the company agreed to an all-stock merger with its European peer Just Eat Takeaway (OTC: TKAY.Y), […]

read more
Why Seattle Genetics Shares Climbed 48.7% in the First Half
What happened Seattle Genetics (NASDAQ: SGEN) shares rose 48.7% in the first half, according to data provided by S&P Global Market Intelligence, after the company gained U.S. regulatory approval for its second drug in less than six months. Image source: Getty Images. The U.S. Food and Drug Administration in April approved Tukysa for patients with metastatic HER2-positive breast cancer after approving Padcev in December for locally advanced or metastatic urothelial cancer. In Padcev's first […]

read more
Google Stays in the Augmented Reality Race with a New Acquisition
Alphabet's (NASDAQ: GOOG) (NASDAQ: GOOGL) Google recently agreed to buy North, a Canadian start-up that produces smart glasses. Google didn't disclose the size of the deal, but The Globe and Mail pegs the value at around $180 million. North's Focal smart glasses look more like regular glasses than the original Google Glass, which had a protruding camera. However, a limited number of apps, a cumbersome fitting process, and a lofty launch price of $1,000 (cut to $600 just weeks later) all doomed […]

read more
How This Apple iPhone Rumor Could Boost Sales
There has been a lot of chatter recently about some secondary details Apple (NASDAQ: AAPL) is working out for the next iPhone in terms of pricing and accessories. The grapevine suggests that the next-generation device may come without an important accessory -- a power adapter -- and could also force buyers to invest in aftermarket (and potentially wireless) headphones as the box may be devoid of EarPods. At the same time, there are rumors of Apple pricing the base model of the alleged iPhone 12 […]

read more

As seen on...